Multiple Sclerosis and Related Disorders

Papers
(The H4-Index of Multiple Sclerosis and Related Disorders is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis73
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study68
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS61
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis57
57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients57
143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry55
157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects54
125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports53
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran44
Lipid measures are associated with cognitive functioning in multiple sclerosis patients41
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America40
“It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis39
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease38
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)37
Involvement Peripheral Nerve System in Multiple Sclerosis36
Characterizing causal relationships of visceral fat and body shape on multiple sclerosis risk35
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study35
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study35
Sexual Dysfunctions and Self-Esteem in Multiple Sclerosis: A Tunisian Study35
Index of cardiac-electrophysiological balance in relapsing–remitting multiple sclerosis patients treated with fingolimod35
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination34
Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?34
Can neurofilament lightchain as endpoint in Phase 2 derisk clinical disability worsening in Phase 3 in multiple sclerosis?33
Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience33
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis33
Nutritional status and taste impairment in adult patients with multiple sclerosis and dysphagia. A pilot study30
Sexual problems in MS: Sex differences and their impact on quality of life30
Glucagon-like peptide-1 agonist safety and efficacy in a multiple sclerosis cohort30
How Much Is Enough? Determining Minimum Valid Tracking Periods for Reliable Physical Activity Monitoring29
Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study29
Relationship between cognitive disturbances and sleep disorders in multiple sclerosis is modulated by psychiatric symptoms29
Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesis29
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis29
1.7321529388428